Evidence map›Paper›PMID 37515290›Full record

ArticleViruses2023

Unveiling the Impact of the Omicron Variant: Insights from Genomic Surveillance in Mato Grosso do Sul, Midwest Brazil.

Lívia de Mello Almeida Maziero, Marta Giovanetti, Vagner Fonseca, Marina Castilhos Souza Umaki Zardin, Gislene Garcia de Castro Lichs, Grazielli Rocha de Rezende Romera, Daniel Henrique Tsuha, Danila Fernanda Rodrigues Frias, Valdir Castanho Escandolhero, Luiz Henrique Demarchi and 14 more

Abstract read
In one paragraph

Article in Viruses, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Lívia de Mello Almeida MazieroSecretaria de Estado de Saúde de Mato Grosso do Sul, Campo Grande 9031-350, Brazil.ORCID 0000-0003-4273-9834
Marta GiovanettiInstituto Rene Rachou, Fundação Oswaldo Cruz, Preto 30190-009, Brazil.ORCID 0000-0002-5849-7326
Vagner FonsecaCoordenação de Vigilância, Preparação e Resposta à Emergências e Desastres (PHE), Organização Pan-Americana da Saúde/Organização Mundial da Saúde (OPAS/OMS), Brasília 25045-002, Brazil.ORCID 0000-0001-5521-6448
Marina Castilhos Souza Umaki ZardinSES-MS-Laboratório Central de Saúde Pública de Mato Grosso do Sul, Campo Grande 79080-320, Brazil.
Gislene Garcia de Castro LichsSES-MS-Laboratório Central de Saúde Pública de Mato Grosso do Sul, Campo Grande 79080-320, Brazil.
Grazielli Rocha de Rezende RomeraSecretaria de Estado de Saúde de Mato Grosso do Sul, Campo Grande 9031-350, Brazil.
Daniel Henrique TsuhaSecretaria de Estado de Saúde de Mato Grosso do Sul, Campo Grande 9031-350, Brazil.
Danila Fernanda Rodrigues FriasSecretaria de Estado de Saúde de Mato Grosso do Sul, Campo Grande 9031-350, Brazil.
Valdir Castanho EscandolheroSecretaria de Estado de Saúde de Mato Grosso do Sul, Campo Grande 9031-350, Brazil.
Luiz Henrique DemarchiSES-MS-Laboratório Central de Saúde Pública de Mato Grosso do Sul, Campo Grande 79080-320, Brazil.ORCID 0000-0001-8693-7897
Larissa Domingues CastilhoSecretaria de Estado de Saúde de Mato Grosso do Sul, Campo Grande 9031-350, Brazil.
Karine Ferreira BarbosaSecretaria de Estado de Saúde de Mato Grosso do Sul, Campo Grande 9031-350, Brazil.ORCID 0000-0003-0034-4500
Danielle Galindo Martins TebetSecretaria de Estado de Saúde de Mato Grosso do Sul, Campo Grande 9031-350, Brazil.
Joilson XavierInstituto Rene Rachou, Fundação Oswaldo Cruz, Preto 30190-009, Brazil.ORCID 0000-0003-3916-2018
Hegger FritschInstituto Rene Rachou, Fundação Oswaldo Cruz, Preto 30190-009, Brazil.ORCID 0000-0002-1997-5786
Mauricio LimaInstituto Rene Rachou, Fundação Oswaldo Cruz, Preto 30190-009, Brazil.ORCID 0000-0002-0830-3909
Carla de Oliveiralnstituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro 21040-900, Brazil.ORCID 0000-0002-0829-036X
Elaine Vieira SantosFundação Hemocentro de Ribeirão Preto, Rio de Janeiro 14015-160, Brazil.
Simone KashimaFundação Hemocentro de Ribeirão Preto, Rio de Janeiro 14015-160, Brazil.
Rodrigo Fabiano do Carmo SaidOrganização Pan-Americana da Saúde/Organização Mundial da Saúde (OPAS/OMS), Brasilia 25045-002, Brazil.
Alexander RosewellOrganização Pan-Americana da Saúde/Organização Mundial da Saúde (OPAS/OMS), Brasilia 25045-002, Brazil.
Julio CrodaFundação Oswaldo Cruz, Universidade Federal de Mato Grosso do Sul-UFMS, Campo Grande 79081-746, Brazil.
Luiz Carlos Junior AlcantaraInstituto Rene Rachou, Fundação Oswaldo Cruz, Preto 30190-009, Brazil.
Crhistinne Cavalheiro Maymone GonçalvesSecretaria de Estado de Saúde de Mato Grosso do Sul, Campo Grande 9031-350, Brazil.ORCID 0000-0001-6953-4965

Funding

University of Washington Arboviral Research Network (UWARN)U01AI151698 · NIAID · UNIVERSITY OF WASHINGTON · PI Michael Gale, PETER MACGARR RABINOWITZ · 2020 to 2026
$13.3M
NIAID NIH HHS U01 AI151698
6 · The paper itself

Abstract

Genomic surveillance has emerged as a crucial tool in monitoring and understanding the dynamics of viral variants during the COVID-19 pandemic. In the Midwest region of Brazil, Mato Grosso do Sul has faced a significant burden from the SARS-CoV-2 epidemic, with a total of 613,000 confirmed cases as of June 2023. In collaboration with the Central Public Health Laboratory in the capital city of Campo Grande, we conducted a portable whole-genome sequencing and phylodynamic analysis to investigate the circulation of the Omicron variant in the region. The study aimed to uncover the genomic landscape and provide valuable insights into the prevalence and transmission patterns of this highly transmissible variant. Our findings revealed an increase in the number of cases within the region during 2022, followed by a gradual decline as a result of the successful impact of the vaccination program together with the capacity of this unpredictable and very transmissible variant to quickly affect the proportion of susceptible population. Genomic data indicated multiple introduction events, suggesting that human mobility played a differential role in the variant's dispersion dynamics throughout the state. These findings emphasize the significance of implementing public health interventions to mitigate further spread and highlight the powerful role of genomic monitoring in promptly tracking and uncovering the circulation of viral strains. Together those results underscore the importance of proactive surveillance, rapid genomic sequencing, and data sharing to facilitate timely public health responses.

Indexed as

COVID-19PandemicsBrazilGenomicsHumansSARS-CoV-2genomic monitoringMato Grosso do SulOmicron variantSARS-CoV-2

Identifiers

PMID37515290
PMCPMC10386548

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.